Skip to main content

Advertisement

Table 5 Validity estimates for miR’s promoter methylation as markers for PCa in urine samples (Cohort #3)

From: MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors

microRNA Sensitivity % (n positive/n total) Specificity (%) PPV (%) NPV (%) Accuracy (%)
miR-34b/c 89.5 (85/95) 47.8 78.0 68.8 75.9
miR-193b 91.6 (87/95) 95.7 97.8 84.6 92.9
miR-34b/c+miR-193b 90. 5% (86/95) 97.8 98.9 83.3 92.9